Matching slides 118,471
Current window 101,791-101,820
Pages 3,950
Rows per page 30
Component: Paragraphclear collectionreset all

Component

101,791-101,820 of 118,471

filter-aware
01
Slide 1
Includes exhibit reference and confidentiality disclaimer.Houlihan Lokey | Investment Banking Pitch Book | 8 slides · Houlihan Lokey
Consulting deck Investment bank 1 hit
03
Includes detailed footnotes regarding assumptions and specific investor commitments.Houlihan Lokey | Investment Banking Pitch Book | 8 slides · Houlihan Lokey
Consulting deck Investment bank Beat · Problem1 hit
05
Includes footnotes regarding specific investor conditions and disclaimers about the nature of the funding.Houlihan Lokey | Investment Banking Pitch Book | 8 slides · Houlihan Lokey
Consulting deck Investment bank Beat · Problem1 hit
08
Houlihan Lokey | Investment Banking Pitch Book | 8 slidesHoulihan Lokey | Investment Banking Pitch Book | 8 slides · Houlihan Lokey
Consulting deck Investment bank 1 hit
01
Slide 1
Matson | Results Presentation Deck | 18 slidesMatson | Results Presentation Deck | 18 slides · Matson
Conference presentation Investor relations Beat · Setup1 hit
18
Includes a detailed footnote explaining the definition and limitations of EBITDA as a non-GAAP measure.Matson | Results Presentation Deck | 18 slides · Matson
Conference presentation Investor relations 1 hit
01
Slide 1
Nuvalent | Investor Presentation Deck | 42 slidesNuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
05
The slide uses a timeline-based structure to demonstrate historical progress and future financial stability.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
06
The slide uses a timeline visual to connect high-level goals with specific 2024 milestones.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
10
Uses a case study (Osimertinib) to validate the proposed strategy for ALK/ROS1 targets.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · Solution1 hit
12
The slide uses a sidebar 'AT A GLANCE' to summarize key clinical development parameters.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
16
The slide uses two distinct chart types (bar and scatter) to demonstrate pharmacological advantages.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
17
Includes detailed patient enrollment breakdown by dose cohort and trial phase.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
25
The slide uses a three-column layout to segment the market by treatment line (3L+, 2L, 1L) and define the specific clinical opportunity for each.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
26
Includes a table detailing patient cohorts and study objectives.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
27
The slide uses a sidebar 'AT A GLANCE' to summarize key clinical and regulatory status.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
31
The slide provides a detailed breakdown of patient enrollment across different dose cohorts (25mg to 125mg QD) for the ARROS-1 trial.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
33
Includes a waterfall plot and a summary table of best responses.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
38
The slide outlines a multi-cohort clinical trial design with specific patient segments based on prior treatment history.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
39
The slide uses a 'ribbon' style callout box on the right for the 'At a Glance' summary.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
42
Nuvalent | Investor Presentation Deck | 42 slidesNuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
36
Oatly | Results Presentation Deck | 43 slidesOatly | Results Presentation Deck | 43 slides · Oatly
Conference presentation Investor relations 1 hit
01
Slide 1
South Plains Financial | Investor Presentation Deck | 27 slidesSouth Plains Financial | Investor Presentation Deck | 27 slides · South Plains Financial
Pitch deck Investor relations 1 hit
15
The slide uses a drill-down approach to show the composition of noninterest income.South Plains Financial | Investor Presentation Deck | 27 slides · South Plains Financial
Pitch deck Investor relations Beat · Financials1 hit
03
The slide serves as a company introduction/cover slide, featuring the brand logo and a product screenshot.Vivid Seats | Investor Presentation Deck | 22 slides · Vivid Seats
Pitch deck Investor relations 1 hit
08
The slide emphasizes the ecosystem value of Skybox, including integrations and upcoming product launches.Vivid Seats | Investor Presentation Deck | 22 slides · Vivid Seats
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
11
The slide uses a split-screen layout to contrast the 'Loyalty Program' and 'Gamified Engagement' pillars.Vivid Seats | Investor Presentation Deck | 22 slides · Vivid Seats
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
22
The table includes both absolute dollar values and percentage margins for each line item across eight quarters.Vivid Seats | Investor Presentation Deck | 22 slides · Vivid Seats
Pitch deck Investor relations 1 hit
01
Slide 1
Yatsen | Results Presentation Deck | 20 slidesYatsen | Results Presentation Deck | 20 slides · Yatsen Holding Limited
Conference presentation Investor relations Beat · Attention1 hit
17
The chart highlights the impact of goodwill impairment on operating expenses in 4Q2023 and FY2023.Yatsen | Results Presentation Deck | 20 slides · Yatsen Holding Limited
Conference presentation Investor relations Beat · Satisfaction1 hit